OBESITY
Obesity is a complex condition with multiple causes, involving a mix of biological, behavioral, environmental, genetic, and medical factors. Here's a structured breakdown:
π§ 1. Behavioral and Lifestyle Causes
Excess calorie intake (especially processed, high-fat, high-sugar foods)
Physical inactivity or sedentary lifestyle
Irregular eating patterns (e.g., late-night eating, binge eating)
Sleep deprivation (disrupts appetite hormones like leptin and ghrelin)
Stress or emotional eating
𧬠2. Genetic and Biological Causes
Family history of obesity (strong genetic predisposition)
Basal metabolic rate (BMR) variations
Hormonal imbalances (e.g., leptin resistance, insulin resistance)
Gut microbiome differences (altered bacterial composition can affect metabolism)
π₯ 3. Medical and Endocrine Causes
Hypothyroidism
Polycystic Ovary Syndrome (PCOS)
Cushing's syndrome
Growth hormone deficiency
Insulinoma or other metabolic disorders
π 4. Medications
Certain drugs can lead to weight gain:
Corticosteroids
Antipsychotics (e.g., olanzapine, clozapine)
Antidepressants (e.g., SSRIs, tricyclics)
Antiepileptics (e.g., valproate)
Insulin and some oral hypoglycemics
π 5. Environmental and Social Factors
Obesogenic environment (easy access to unhealthy foods, food marketing)
Urbanization (reduced physical activity opportunities)
Low socioeconomic status (limited access to healthy food, exercise)
Cultural norms around food and body image
πΆ 6. Early Life and Developmental Factors
Maternal obesity or diabetes during pregnancy
Low birth weight or rapid infant weight gain
Early childhood nutrition patterns
π Summary:
Obesity is not just a matter of willpower β itβs influenced by a complex interplay of factors including:
Energy imbalance (intake > expenditure)
Genetics
Hormones
Environment
Medical conditions or medications
β General Recommendations for Weight Loss
πΉ 1. Diet and Nutrition
Create a calorie deficit: Aim to reduce intake by 500β750 kcal/day to lose ~0.5β1 kg/week
Choose a nutrient-dense, low-calorie diet:
High in vegetables, fruits, whole grains, lean proteins
Low in refined sugars, processed foods, saturated fats
Consider evidence-based dietary patterns:
Mediterranean diet
DASH diet
Low-carb or low-fat diets, if sustainable
Portion control and mindful eating strategies help prevent overeating
Limit sugar-sweetened beverages and alcohol
πΉ 2. Physical Activity
At least 150β300 minutes/week of moderate-intensity aerobic activity (e.g., brisk walking, cycling)
Include resistance training 2β3 times/week to preserve muscle mass
Increase daily movement (e.g., take stairs, reduce screen time)
πΉ 3. Behavioral and Lifestyle Interventions
Self-monitoring: food diaries, activity logs, weight tracking
Goal setting: realistic, specific, time-based
Cognitive-behavioral therapy (CBT) or structured programs for long-term adherence
Identify and manage triggers for emotional or stress eating
Sleep: Ensure 7β9 hours/night, as poor sleep increases hunger hormones
πΉ 4. Medical Therapy (if BMI β₯30 or β₯27 with comorbidities)
Pharmacotherapy options include:
GLP-1 receptor agonists (e.g., semaglutide)
Orlistat, naltrexone/bupropion, or phentermine/topiramate
Must be combined with lifestyle modification
πΉ 5. Bariatric Surgery (if BMI β₯40 or β₯35 with comorbidities)
Consider if lifestyle and medical treatments fail
Procedures: Sleeve gastrectomy, gastric bypass, etc.
Requires lifelong follow-up, dietary changes, and vitamin supplementation
π― Target Weight Loss Goals
Initial goal: 5β10% of body weight over 6 months
Even modest weight loss can:
Improve blood pressure, glucose, and lipids
Reduce risk of type 2 diabetes, heart disease, and sleep apnea
Here is a list of medications used for the treatment of obesity, typically indicated for patients with:
BMI β₯30, or
BMI β₯27 with obesity-related comorbidities (e.g., hypertension, diabetes, dyslipidemia)
These medications are used alongside lifestyle modifications.
π FDA-Approved Medications for Obesity
Medication | Mechanism of Action | Common Side Effects | Notes |
|---|---|---|---|
Orlistat (Xenical, Alli) | Inhibits pancreatic lipase β β fat absorption | GI: oily stools, flatulence, diarrhea | Available OTC (lower dose as Alli); take with low-fat meals |
Phentermine | Sympathomimetic β appetite suppression | β BP, insomnia, palpitations, dry mouth | Short-term use only (β€12 weeks); C-IV controlled |
Phentermine/Topiramate ER (Qsymia) | Appetite suppression & satiety enhancement | Paresthesia, insomnia, dry mouth, teratogenic | Avoid in pregnancy; requires titration and REMS program |
Naltrexone/Bupropion ER (Contrave) | Affects reward pathways and appetite control | Nausea, headache, insomnia, β BP | Avoid in seizure disorders, uncontrolled hypertension, or opioid use |
Liraglutide (Saxenda) | GLP-1 agonist β satiety, delayed gastric emptying | Nausea, vomiting, diarrhea | Daily subcutaneous injection; also used for T2DM (Victoza) |
Semaglutide (Wegovy) | GLP-1 agonist β strong appetite suppression | Nausea, constipation, fatigue | Weekly subcutaneous injection; shown to produce β₯15% weight loss |
Tirzepatide (Zepbound)(approved 2023) | Dual GLP-1/GIP agonist β powerful appetite and glucose regulation | GI side effects, similar to semaglutide | Weekly injection; also approved as Mounjaro for T2DM |
β Medications Not Recommended
Metformin: sometimes used off-label, modest weight loss in insulin resistance/PCOS
Thyroid hormones, diuretics, and amphetamines are not appropriate for weight loss in obesity without specific indications
π Key Considerations
Always combine medication with diet and exercise
Assess efficacy after 12 weeks at target dose:
Discontinue if weight loss is <5%
Monitor for side effects, drug interactions, contraindications